Breaking Quebec’s Governing Party Names Donald Trump ‘Real Adversary’ in Election Campaign Launch Buffalo Bills Edge Pittsburgh Steelers 28-27 in Preseason Finale Chris Sale Pitches Shutout as Braves Sweep Dodgers 1-0 Tampa City Officials Approve $2.3 Billion Deal for New Rays Ballpark Border Wall Construction Proceeds on Tohono O’odham Nation Land Despite Tribal Objections

Thursday August 27, 2026

Reporter

Milestone Pharmaceuticals Inc.

5Articles Published

5Communities Covered

Published Articles

Press Release

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

15 hours ago

Press Release

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

Aug 21

Press Release

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

Aug 21

Press Release

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 12

Press Release

Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026

Aug 4